Carisma Therapeutics, Inc. has been added to NASDAQ Composite Index (^COMP).
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.49 USD | +0.68% | -6.58% | -49.15% |
09/05 | Carisma Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02/05 | Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.15% | 61.48M | |
+5.26% | 109B | |
+11.35% | 105B | |
-0.03% | 22.25B | |
-12.18% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-9.93% | 16.85B | |
+4.83% | 13.76B | |
+35.31% | 12.46B |
- Stock Market
- Equities
- CARM Stock
- News Carisma Therapeutics, Inc.
- Carisma Therapeutics, Inc.(NasdaqGM: CARM) added to NASDAQ Composite Index